Category Archives: Stem Cell Research
Surgeons Urge Caution: Stem Cell Treatments Untested in Aesthetic Surgery
Dallas, TX (PRWEB) February 22, 2012 There is little evidence to support the safety and effectiveness of procedures, equipment and treatments that have been advertised using adult stem cells for aesthetic reconstruction, including plastic surgery and facial rejuvenation, according to physicians writing in Plastic and Reconstructive Surgery. Dr. Rod J. Continue reading
Cancer Stem Cell Research Drives Growth in RBCC’s Target Market
NOKOMIS, Fla.–(BUSINESS WIRE)– Research into Cancer Stem Cells (CSC) is on the rise, fueling industry growth that Rainbow Coral Corp. (OTCBB: RBCC.OB – News) expects to translate into demand for n3D cell growth technologies. Continue reading
Cancer Stem Cell Research – Video
28-07-2010 10:24 Dr. Ed Prochownik, director of Oncology Research at Children’s Hospital of Pittsburgh of UPMC, discusses his research on cancer stem cells published in the June issue of the journal Stem Cells. Continue reading
Celling Biosciences Sponsors 7th Annual Stem Cell Summit
AUSTIN, Texas, Feb. 21, 2012 /PRNewswire/ – Celling Biosciences announces a sponsorship of the 7th Annual Stem Cell Summit being held on February 21st at Bridgewaters New York in New York City. Continue reading
Qatari students to present research on stem cells
Research on the potential of stem cells in preventing ovarian cancer, obesity-related diseases and other serious illnesses affecting people in Qatar and the region is to be presented by three Qatari graduate students at the Qatar International Conference on Stem Cell Science and Policy next week. The conference is organised by Qatar Foundation for Education, Science and Community Development (QF) and James A Baker III Institute for Public Policy. Continue reading
Stem cell implants boost monkeys with Parkinson's
Monkeys suffering from Parkinson's disease show a marked improvement when human embryonic stem cells are implanted in their brains, in what a Japanese researcher said Wednesday was a world first. A team of scientists transplanted the stem cells into four primates that were suffering from the debilitating disease Continue reading
ISSCR’s 10th Anniversary Featuring Leonard Zon, MD – Video
14-02-2012 11:39 ISSCR Founding Member, Leonard Zon, MD, talks about ISSCR’s 10th anniversary and the impact it’s had on stem cell research. Continue reading
Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis
A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients. “Autologous Stromal Vascular Fraction Therapy for Rheumatoid Arthritis: Rationale and Clinical Safety,” which appears in the January publication of the International Archives of Medicine, followed 13 rheumatoid arthritis patients who were treated with their own fat-derived stem cells. Dallas, TX (PRWEB) February 21, 2012 A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients Continue reading
Russian Press – Behind the Headlines, February 20
Moskovskiye Novosti Church Calls for Ban on Stem Cell Research The Russian Orthodox Church has called for recognizing fetuses as human life and for banning medical research that involves biological material procured from abortion procedures. The church has sent a series of amendments to the cell technology bill, which iscurrently in the works, to Healthcare Minister Tatyana Golikova in the hope that “the ministry will heed its opinion.” “We, in turn, are ready for dialogue and discussion on each proposal,” said Bishop Panteleimon, head of the the Synodal Department for Church Charity and Social Ministry Continue reading
Sigma® Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio, Deepens Commitment to …
ST. LOUIS, Mo., Feb. 21, 2012 /PRNewswire/ – Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services research business, has furthered its commitment to stem cell research, drug discovery and ADME/Toxicology by acquiring a worldwide license to use Kyoto University's induced pluripotent stem (iPS) cell patent portfolio Continue reading